|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.08.26 - 15:33
|
NeuroSense Issues CEO Letter to Shareholders (PR Newswire)
|
|
|
CAMBRIDGE, Mass., Aug. 13, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases, today releases a letter from the CEO, Alon Ben-Noon,......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|